RARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process. Disclaimer:
|
|
- Theodore Newton
- 6 years ago
- Views:
Transcription
1 RARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the Kakkis EveryLife Foundation, for educational purposes only. They are for use by drug development professionals and statisticians, and are not to be used to guide the prescribing or use of any of the drugs mentioned in the slides. To obtain information on a particular drug, refer to the drug labeling. Do not reproduce or distribute the slides (full set or any portion of) without the permission of the author.
2 KAKKIS Foundation Clinical Evaluation of Rare Disease Treatments June 14-15, 2011 Washington DC James Witter MD, PhD Chief Science Officer NIH/NIAMS Dynamic Tools to Measure Health Outcomes from the Patient Perspective
3 The Tower of Babel (Brueghel, 1563)
4 Vision-Mission: Vision The Patient-Reported Outcomes Measurement Information System (PROMIS), funded by the National Institutes of Health, aims to provide clinicians and researchers access to efficient, precise, valid, Click and responsive to edit adult- Master and title child-reported style measures of health. Mission PROMIS uses measurement science to create an efficient state-of-the-art assessment system for selfreported health.
5 Overall Framework: Assessments Dimension Objectiveness Clinical Measure (Some Non-objective element Involved) Biomarker Who measures Patient Clinician Observer Instrument Relationship to Tangible Clinical Benefit Direct Indirect Direct Indirect Direct Indirect Indirect How obtained Naturalistic Artificial Procedure VAS for pain intensity; NONE Possible PANSS for schizophrenia symptoms NONE Possible Observation of seizures for epilepsy outcomes NONE Possible HbA1c for cardiovascular outcomes; endocrine stimulation tests for endocrine organ function) 2 nd Annual Critical Path Institute-PRO Consortium: FDA Workshop March 15, 2011 Silver Spring, MD
6 NIH Assessment Tools NIH Toolbox Assessment of Neurological and Behavioral Function Neuro-QOL Quality of Life in Neurological Disorders The EXAMINER Neurobehavioral Evaluation and Research Phen-X Consensus Measures for Phenotypes and Exposures PROMIS Patient-Reported Outcomes Measurement Information System
7 Patient-Reported Outcomes (PROs) FDA and NIH recognize PROs as important outcomes to answer clinical questions translating the efficacy-effectiveness and safety of therapeutics In development (clinical research) In the real world (clinical care) Click to edit Master title style Patient burden is important aspect of PRO assessment in both these settings
8
9 PROMIS: Present Click to edit Master title style
10 FDA/C-PATH PRO Process FDA/C-Path meeting: Dec. 4, 2008
11 Domain development/qualification-validation lifecycle -Maturity Model- Fully test domain Industry sponsored Secondary endpoints Primary endpoints National surveys CDC NIH phase II-III studies establish MID Clinical care Click to edit Master title style Psychometrically focused testing Clinically focused testing Domain: Selection Content Expert Review Healthy People-Patient Centered: Cross Sectional Cognitive testing Focus groups Fully develop domain Items administered to representative sample and calibrated for widespread use: Web-based (large numbers) Patient groups
12 PROMIS Domain Framework
13 Items from Instrument A Items from Instrument B Items from Instrument C New Items Item Pool Probability of Response Content Expert Review Category Response Short Form Instruments Theta Focus Groups Questionnaire administered to large representative sample Psychometric Testing Cognitive Testing Item Bank v. 1 Domain (IRT-calibrated items, reviewed for reliability-validity-sensitivity) 2.5 Information DIF (2 0 )Analysis Theta CAT Item Information
14 PROMIS Wave 1 Samples Site (n=329) Demo. short form Global health General population (n=329) UNC=236 Full Bank Testing (N=7,005) Forms A-G Legacy Polimetrix (n=6,676) Stanford=93 Demo. short form Global health General population (n=6,676) Forms A-G Legacy Co-morbidity Site (n=1,203) General population (n=400) UNC=304 Stanford=96 Block Testing (N=14,128) Demo. extended form Global health Forms H-W Co-morbidity Polimetrix (n=12,925) Demo. extended form Global health Forms H-W Co-morbidity Clinical sample (n=803) General population (n=5,845) Clinical sample (n=7,080) Pittsburgh=252 Stanford=150 Duke=401
15 The PROMIS Validation Process Qualitative Research and Item Writing Item Testing General Population Clinical Samples Click to edit Master title style Bank Analysis Interpretation Refining
16 PROMIS combines: Item Response Theory (IRT) and Computer Adaptive Testing (CAT) Together, IRT and CAT provide precise measurement Click to edit of Master individual title style symptoms
17 Item Response Theory In psychometrics- body of theory that: Describes application of mathematical models to how people respond to items» At person and item level Serves as basis for measuring Click to edit Master title style» Abilities» Attitudes Based on probability of endorsing a particular item category is function of latent trait or ability Ability to improve reliability of instrument
18 Definitions Items are questions that have: Context, stems, responses Parameters (Difficulty, Discrimination) Important for analyses, calibration Banks Click to edit Master title style Collection of items that have been calibrated on a common metric difficulty and discrimination have been estimated Define common concept-domain Domains Allow computerized adaptive testing (CAT) Define latent traits/abilities
19 A domain is the specific feeling, function, or perception you want to measure. Examples Fatigue Pain Anxiety
20 A domain is the specific feeling, function, or perception you want to measure. Examples Physical function Erectile function
21 A domain is the specific feeling, function, or perception you want to measure. Examples Satisfaction with Social Participation General Health Perceptions
22 An item bank is a large collection of items measuring a single domain. Any and all items can be used to provide a score for that domain.
23 IRT models Latent Traits: People and Items are Represented on the Same Scale Are you able to get out of bed. Item Difficulty Are you able to run 5 miles Low Low High High Persons Levels of Physical Function 23
24
25 PROMIS Current Physical Health Banks
26 PROMIS Current Mental Health Banks
27 PROMIS Current Social Health Banks
28 PROMIS Adult Banks: v1.0 Items in Domains Items in Bank Short Form Emotional Distress Anger 29 8 Emotional Distress Anxiety 29 7 Emotional Distress Depression 28 8 Fatigue 95 7 Click to edit Master title style Pain Behavior 39 7 Pain interference 41 6 Physical Function Satisfaction with Discretionary Social Activities 12 7 Satisfaction with Social Roles 14 7 Sleep Disturbance 27 8 Wake Disturbance (sleep related impairment) 16 8 Global Health 10
29 PROMIS II Expanded Focus on Children 4 of the 12 research sites are devoted to child-reported outcome measurement
30 Child-Adult Linkage Studies Render child and adult editions comparable (i.e., same scale) Result: life course outcome assessment
31 Pediatric PROMIS Item Banks PROMIS I 1. Physical functioning/mobility 2. Physical functioning/upper extremity 3. Pain interference 4. Fatigue 5. Depressive symptoms 6. Anxiety 7. Anger 8. Peer relationships 9. Asthma impact PROMIS II 1. Pain behavior 2. Pain quality 3. Physical activity/mobility 4. Physical activity/sedentary 5. Experiences of stress 6. Physical distress 7. Life satisfaction 8. Positive affect 9. Meaning and purpose 10. Family belonging 11. Family involvement
32 PROMIS Profile Short Forms ( items) Mental Anxiety 29 Depression Fatigue 95 Physical Pain Impact 41 Sleep Disturbance 27 Physical Function 86 Social Satisfaction with Roles
33 Value of PROMIS : Comparability Validity and Reliability Flexibility Inclusiveness Click to edit Master title style
34 Comparability Chemotherapy trial Osteoarthritis trial Heart failure trial
35 Reliability and Validity
36 Physical Functioning: Improved Precision vs. Legacy SF items P re reliability = 0.90 c i s i o n Standard error HAQ 20 items 10 item CAT SE = 0.32 reliability = 0.95 SE = 0.22 SF-36 full bank Disabled rheumatoid arthritis patients normed theta values 10 item PROMIS CAT US General Population mean High physical functioning
37 Flexibility
38 Linking PROMIS and EHRs SNOMED and LOINC codes
39 Inclusiveness
40
41 Computerized Adaptive Testing (CAT) Integrates IRT with computers to administer a PRO instrument selects questions on the basis of a patient s response to previously administered questions Click to edit Master title style measurement is adapted to individual skips uninformative items to minimize response burden allows determination of person s standing on a domain without a loss in measurement precision.
42 CAT: Estimate gets more precise with every question Q1: Q2: SEM after each question Q3: Q4: Q5:
43
44 What is Assessment Center? Web-based research management tool Primary mechanism for distribution of PROMIS instruments Display of item- and instrument-level statistics Allows Click creation to edit Master of study-specific title style URLs for data collection Enabled to administer CATs Administration of PROMIS and other instruments FREE!!
45 Select CATs Click to edit Master title style
46 CAT Report Graph Click to edit Master title style
47 Effect Size: PROMIS Pain Behavior 1.6 vs. Roland-Morris Pain Behavior (4 (4-4) items) Roland-Morris (24 items) effect size time point
48 Mean Difference: PROMIS Pain Interference vs. BPI Interference (pain) Mean difference from baseline time point PROMIS Pain Interference (4 (4-12) items) BPI Interference (7 items)
49 PROMIS Integration Options Study-specific URL in Assessment Center PROMIS and other self-reported data: -able link to respondents Online consent and assent Standalone study or run as sub-study Downloadable modules for local installation Redcap: includes PROMIS short-forms Short-forms can be added to SurveyMonkey, epro, etc. PROsetta Stone linking measures to common PROMIS metric Electronic Health Records & Personal Health Records LOINC and SNOMED codes have been assigned to PROMIS measures
50 Advancing Patient-Centered Outcomes PROMIS: A Common Source of PROs Clinical Practice Click to edit Master title style Surveys (CDC) Clinical research Clinic Hospital NIH Industry FDA
51 Patient-Reported Outcomes: PROs PROs - Biomarkers FDA guidance: Qualification of Drug Development Tools (Oct. 2010) nces/ucm pdf PROs to dissect mechanisms Knee OA Pain: AC&R July 2010 Click to edit Master title style neuropathic pain descriptors Burning, tingling, numbness, pins & needles PROs to describe disease SLE: Self-Assessed Lupus Damage Instrument AC&R: April 2010 RA: Patient-based Disease Activity Score AC&R: Feb 2008
52 Enhancing Pediatric Pain Pediatric Rheumatology and Rehabilitation Research Dr. Esi Morgan DeWitt-CCHMC Demonstrate validity and responsiveness in conditions that impair physical function and HRQOL Chronic pain conditions (140 children: ages 8-18) Juvenile idiopathic arthritis (120 children) Click Cerebral to palsy edit (60 children, Master 120 title parents) style Study content validity (interviews) Longitudinal study Three assessments: includes pain interference CAT and SF Develop & Test Pain Behavior and Quality Item Banks 450 children chronic: MS pain, JIA, sickle cell disease Facilitate Linking studies (Lifecycle) with adult banks
53
54 Patient-Reported Outcomes: PROs PROs measure symptoms which reflect biopsychosocial mechanisms of disease Items/questions capture symptoms Items capture mechanisms of disease PROs add to: Objective-biomarkers of disease Physician opinion regarding disease Engage patient in their care and treatment facilitate personalized care
55 DOMAINS vs. DISEASES Diseases (common & rare) are combinations of different mechanisms which impact domains Capturing multiple domains may be optimal way to assess diseases Core-common PRO domains are universally applicable across diseases, ages and ethnicities Core PRO domains can link common and rare diseases
56 A model for PROs in RA Pain Physical Function Morning stiffness Fatigue Sleep Disturbance Depression/anxiety Sexuality Satisfaction with social roles Capacity to work Family belonging Self efficacy
57 Rare Diseases Domain Validation-Qualification Numbers/Types of Trials? Clinically focused testing 0 Psychometrically focused testing
58 PROMIS Options -public private partnerships- Clinical, Translational, & CE Research Registries Population Surveillance Clinical Practice
PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases
PROMIS Overview: Development of New Tools for Measuring Health-related Quality of Life and Related Outcomes in Patients with Chronic Diseases William Riley, Ph.D. National Heart, Lung, and Blood Institute
More informationThe Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System
The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System Gene A. Kallenberg, MD Professor and Chief, Division of Family Medicine Director, UCSD Center for Integrative
More informationThe Future of Measuring Patient-Reported Outcomes in Rheumatology
Arthritis Care & Research Vol. 63, No. S11, November 2011, pp S486 S490 DOI 10.1002/acr.20581 2011, American College of Rheumatology COMMENTARY The Future of Measuring Patient-Reported Outcomes in Rheumatology
More information3/5/2014. New Research Initiatives to Improve QoL of Persons with SCI Across the Globe. What Are the SCI International Datasets?
New Research Initiatives to Improve QoL of Persons with SCI Across the Globe International SCI Conference: Toward Better Quality of Life Sultan Bin Abdulaziz Humanitarian City Riyadh, KSA Tamara Bushnik,
More informationPatient Reported Outcomes in Clinical Research. Overview 11/30/2015. Why measure patientreported
Patient Reported Outcomes in Clinical Research Kevin P. Weinfurt, PhD Introduction to the Principles and Practice of Clinical Research National Institutes of Health November 30, 2015 Overview 1. Why measure
More informationMeasuring Patient Health with PROMIS : Applications for Social Integration Research and Care
Measuring Patient Health with PROMIS : Applications for Social Integration Research and Care Ashley Wilder Smith, PhD, MPH Chief, Outcomes Research Branch, NCI, NIH NIH Chief Science Officer, HealthMeasures
More informationSLEEP DISTURBANCE ABOUT SLEEP DISTURBANCE INTRODUCTION TO ASSESSMENT OPTIONS. 6/27/2018 PROMIS Sleep Disturbance Page 1
SLEEP DISTURBANCE A brief guide to the PROMIS Sleep Disturbance instruments: ADULT PROMIS Item Bank v1.0 Sleep Disturbance PROMIS Short Form v1.0 Sleep Disturbance 4a PROMIS Short Form v1.0 Sleep Disturbance
More informationInstruments Available for Use in Assessment Center
Instruments Available for Use in Assessment Center The Assessment Center Instrument Library includes instruments from PROMIS, Neuro-QoL, NIH Toolbox and Health LiTT. All instruments are available for use
More informationFor more information: Quality of Life. World Health Organization Definition of Health
Health-Related Quality of Life - 10 John E. Ware, Jr., PhD, Professor and Chief Measurement Sciences Division, Department of Quantitative Health Sciences University of Massachusetts Medical School, Worcester,
More informationUtilizing the NIH Patient-Reported Outcomes Measurement Information System
www.nihpromis.org/ Utilizing the NIH Patient-Reported Outcomes Measurement Information System Thelma Mielenz, PhD Assistant Professor, Department of Epidemiology Columbia University, Mailman School of
More informationPAIN INTERFERENCE. ADULT ADULT CANCER PEDIATRIC PARENT PROXY PROMIS-Ca Bank v1.1 Pain Interference PROMIS-Ca Bank v1.0 Pain Interference*
PROMIS Item Bank v1.1 Pain Interference PROMIS Item Bank v1.0 Pain Interference* PROMIS Short Form v1.0 Pain Interference 4a PROMIS Short Form v1.0 Pain Interference 6a PROMIS Short Form v1.0 Pain Interference
More informationPatient Reported Outcomes in Sickle Cell Disease. Marsha J. Treadwell, PhD 5 October 2016
Patient Reported Outcomes in Sickle Cell Disease Marsha J. Treadwell, PhD 5 October 2016 Outline Provide brief overview of key health domains affected by sickle cell disease and that can be measured by
More informationFATIGUE. A brief guide to the PROMIS Fatigue instruments:
FATIGUE A brief guide to the PROMIS Fatigue instruments: ADULT ADULT CANCER PEDIATRIC PARENT PROXY PROMIS Ca Bank v1.0 Fatigue PROMIS Pediatric Bank v2.0 Fatigue PROMIS Pediatric Bank v1.0 Fatigue* PROMIS
More informationINTRODUCTION TO ASSESSMENT OPTIONS
DEPRESSION A brief guide to the PROMIS Depression instruments: ADULT ADULT CANCER PEDIATRIC PARENT PROXY PROMIS-Ca Bank v1.0 Depression PROMIS Pediatric Item Bank v2.0 Depressive Symptoms PROMIS Pediatric
More informationANXIETY A brief guide to the PROMIS Anxiety instruments:
ANXIETY A brief guide to the PROMIS Anxiety instruments: ADULT PEDIATRIC PARENT PROXY PROMIS Pediatric Bank v1.0 Anxiety PROMIS Pediatric Short Form v1.0 - Anxiety 8a PROMIS Item Bank v1.0 Anxiety PROMIS
More informationMEANING AND PURPOSE. ADULT PEDIATRIC PARENT PROXY PROMIS Item Bank v1.0 Meaning and Purpose PROMIS Short Form v1.0 Meaning and Purpose 4a
MEANING AND PURPOSE A brief guide to the PROMIS Meaning and Purpose instruments: ADULT PEDIATRIC PARENT PROXY PROMIS Item Bank v1.0 Meaning and Purpose PROMIS Short Form v1.0 Meaning and Purpose 4a PROMIS
More informationMethodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements
Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics John D Peipert Ron D Hays Acknowledgements Funding for this work provided by the Kidney Care Quality Alliance 1 Patient
More informationPSYCHOLOGICAL STRESS EXPERIENCES
PSYCHOLOGICAL STRESS EXPERIENCES A brief guide to the PROMIS Pediatric and Parent Proxy Report Psychological Stress Experiences instruments: PEDIATRIC PROMIS Pediatric Item Bank v1.0 Psychological Stress
More informationPatient Reported Outcomes in Arthritis, TJR, and Physical Activity Research
University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2016 UMass Center for Clinical and Translational Science Research Retreat
More informationANXIETY. A brief guide to the PROMIS Anxiety instruments:
ANXIETY A brief guide to the PROMIS Anxiety instruments: ADULT ADULT CANCER PEDIATRIC PARENT PROXY PROMIS Bank v1.0 Anxiety PROMIS Short Form v1.0 Anxiety 4a PROMIS Short Form v1.0 Anxiety 6a PROMIS Short
More informationPatient-Centered Endpoints in Oncology
Patient-Centered Endpoints in Oncology SIXTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP April 29-30, 2015 Silver Spring, MD Disclaimer The views and opinions expressed in the following slides
More informationGENERAL SELF-EFFICACY AND SELF-EFFICACY FOR MANAGING CHRONIC CONDITIONS
GENERAL SELF-EFFICACY AND SELF-EFFICACY FOR MANAGING CHRONIC CONDITIONS A brief guide to the PROMIS Self-Efficacy Instruments ADULT PROMIS Item Bank v1.0 General Self-Efficacy PROMIS Short Form v1.0 General
More informationINTRODUCTION TO ASSESSMENT OPTIONS
ASTHMA IMPACT A brief guide to the PROMIS Asthma Impact instruments: PEDIATRIC PROMIS Pediatric Item Bank v2.0 Asthma Impact PROMIS Pediatric Item Bank v1.0 Asthma Impact* PROMIS Pediatric Short Form v2.0
More informationSensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS to ASCQ-Me
Keller et al. Health and Quality of Life Outcomes (2017) 15:117 DOI 10.1186/s12955-017-0661-5 RESEARCH Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease:
More informationWare NIH Lecture Handouts
Health-Related Quality of Life - 11 John E. Ware, Jr., PhD, Professor and Chief Measurement Sciences Division, Department of Quantitative Health Sciences University of Massachusetts Medical School, Worcester,
More informationPHYSICAL FUNCTION A brief guide to the PROMIS Physical Function instruments:
PROMIS Bank v1.0 - Physical Function* PROMIS Short Form v1.0 Physical Function 4a* PROMIS Short Form v1.0-physical Function 6a* PROMIS Short Form v1.0-physical Function 8a* PROMIS Short Form v1.0 Physical
More informationPROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS SLEEP DISTURBANCE AND NEURO-QOL SLEEP DISTURBANCE
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS SLEEP DISTURBANCE AND NEURO-QOL SLEEP DISTURBANCE DAVID CELLA, BENJAMIN D. SCHALET, MICHAEL KALLEN, JIN-SHEI LAI, KARON
More informationPHYSICAL STRESS EXPERIENCES
PHYSICAL STRESS EXPERIENCES A brief guide to the PROMIS Physical Stress Experiences instruments: PEDIATRIC PROMIS Pediatric Bank v1.0 - Physical Stress Experiences PROMIS Pediatric Short Form v1.0 - Physical
More informationJournal of Clinical Epidemiology 63 (2010) 1179e1194
Journal of Clinical Epidemiology 63 (2010) 1179e1194 The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item
More informationABOUT PHYSICAL ACTIVITY
PHYSICAL ACTIVITY A brief guide to the PROMIS Physical Activity instruments: PEDIATRIC PROMIS Pediatric Item Bank v1.0 Physical Activity PROMIS Pediatric Short Form v1.0 Physical Activity 4a PROMIS Pediatric
More informationPROMIS ANXIETY AND KESSLER 6 MENTAL HEALTH SCALE PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS ANXIETY AND KESSLER 6 MENTAL HEALTH SCALE SEUNG W. CHOI, TRACY PODRABSKY, NATALIE MCKINNEY, BENJAMIN D. SCHALET, KARON
More informationPROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS V2.0 COGNITIVE FUNCTION AND FACT-COG PERCEIVED COGNITIVE IMPAIRMENT DAVID CELLA, BENJAMIN D. SCHALET, MICHAEL KALLEN,
More informationPatient Reported Outcomes
Date Patient Reported Outcomes Presented by: Ari Gnanasakthy RTI Health Solutions 9 th Feb 2015 RTI Health Solutions Research Triangle Park, NC, USA Ann Arbor, MI, USA Barcelona, Spain Ljungskile, Sweden
More information10/30/2013. Disclosures. Defining Flares in RA RA Flare Group
Disclosures Using PROMIS Instruments to Identify Disease Flares in People with Rheumatoid Arthritis S Bartlett is the Canadian delegate for PROMIS International Recipient of CIHR planning award for Canada
More informationTable of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix
Table of Contents Preface to the third edition xiii Preface to the second edition xv Preface to the fi rst edition xvii List of abbreviations xix PART 1 Developing and Validating Instruments for Assessing
More informationPROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS GLOBAL HEALTH-PHYSICAL AND VR-12- PHYSICAL
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS GLOBAL HEALTH-PHYSICAL AND VR-12- PHYSICAL DAVID CELLA, BENJAMIN D. SCHALET, MICHAEL KALLEN, JIN-SHEI LAI, KARON F. COOK,
More informationPROMIS PAIN INTERFERENCE AND BRIEF PAIN INVENTORY INTERFERENCE
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS PAIN INTERFERENCE AND BRIEF PAIN INVENTORY INTERFERENCE SEUNG W. CHOI, TRACY PODRABSKY, NATALIE MCKINNEY, BENJAMIN D.
More informationCOGNITIVE FUNCTION. PROMIS Pediatric Item Bank v1.0 Cognitive Function PROMIS Pediatric Short Form v1.0 Cognitive Function 7a
COGNITIVE FUNCTION A brief guide to the PROMIS Cognitive Function instruments: ADULT PEDIATRIC PARENT PROXY PROMIS Item Bank v1.0 Applied Cognition - Abilities* PROMIS Item Bank v1.0 Applied Cognition
More informationPROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS PEDIATRIC ANXIETY AND NEURO-QOL PEDIATRIC ANXIETY
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS PEDIATRIC ANXIETY AND NEURO-QOL PEDIATRIC ANXIETY DAVID CELLA, BENJAMIN D. SCHALET, MICHAEL A. KALLEN, JIN-SHEI LAI,
More informationPROMIS DEPRESSION AND NEURO-QOL DEPRESSION
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS DEPRESSION AND NEURO-QOL DEPRESSION SEUNG W. CHOI, TRACY PODRABSKY, NATALIE MCKINNEY, BENJAMIN D. SCHALET, KARON F. COOK
More informationPROSETTA STONE METHODOLOGY A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES
PROSETTA STONE METHODOLOGY A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES SEUNG W. CHOI, TRACY PODRABSKY, NATALIE MCKINNEY, BENJAMIN D. SCHALET, KARON F. COOK & DAVID CELLA DEPARTMENT OF MEDICAL SOCIAL
More informationHealth-Related Quality of Life (HRQoL)
Health-Related Quality of Life (HRQoL) - 2012 John E. Ware, Jr., PhD, Professor and Chief Measurement Sciences Division, Department of Quantitative Health Sciences University of Massachusetts Medical School,
More informationABOUT SUBSTANCE USE INTRODUCTION TO ASSESSMENT OPTIONS SUBSTANCE USE. 2/26/2018 PROMIS Substance Use Page 1
SUBSTANCE USE A brief guide to the PROMIS Substance Use instruments: ADULT PROMIS Item Bank v1.0 Appeal of Substance Use (Past 3 Months) PROMIS Item Bank v1.0 Appeal of Substance Use (Past 30 days) PROMIS
More informationSmoking Social Motivations
Smoking Social Motivations A brief guide to the PROMIS Smoking Social Motivations instruments: ADULT PROMIS Item Bank v1.0 Smoking Social Motivations for All Smokers PROMIS Item Bank v1.0 Smoking Social
More informationPROMIS DEPRESSION AND CES-D
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS DEPRESSION AND CES-D SEUNG W. CHOI, TRACY PODRABSKY, NATALIE MCKINNEY, BENJAMIN D. SCHALET, KARON F. COOK & DAVID CELLA
More informationPROMIS User Manual (Version 1.1)
USER MANUAL PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) Version. October, 008 COPYRIGHT NOTICE This is an unpublished manual. From October 5, 008 through March 5, 009, please cite
More informationPROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS GLOBAL HEALTH - PHYSICAL COMPONENT AND VR- 12 PHYSICAL COMPONENT (ALGORITHMIC SCORES) DAVID CELLA, BENJAMIN D. SCHALET,
More informationDisclaimer. ISPOR 22 nd Annual International Meeting May 24, 2017 Boston, Massachusetts, USA
A Multi-Stakeholder Collaborative Approach to Developing a Patient-Reported Outcome (PRO) Measure for FDA Drug Development Tool Qualification: The PRO Consortium s Depression Working Group Experience ISPOR
More informationPROMIS ANXIETY AND MOOD AND ANXIETY SYMPTOM QUESTIONNAIRE PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES
PROSETTA STONE ANALYSIS REPORT A ROSETTA STONE FOR PATIENT REPORTED OUTCOMES PROMIS ANXIETY AND MOOD AND ANXIETY SYMPTOM QUESTIONNAIRE SEUNG W. CHOI, TRACY PODRABSKY, NATALIE MCKINNEY, BENJAMIN D. SCHALET,
More informationGLOBAL HEALTH. PROMIS Pediatric Scale v1.0 Global Health 7 PROMIS Pediatric Scale v1.0 Global Health 7+2
GLOBAL HEALTH A brief guide to the PROMIS Global Health instruments: ADULT PEDIATRIC PARENT PROXY PROMIS Scale v1.0/1.1 Global Health* PROMIS Scale v1.2 Global Health PROMIS Scale v1.2 Global Mental 2a
More informationAddressing Content Validity of PRO Measures: The Unique Case of Rare Diseases
Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the Kakkis EveryLife Foundation, for educational purposes only. They are for use by drug development professionals and
More informationCreating a Child Self-Report Measure of Adverse Events Related to Cancer Treatment; Providing a Voice for the Child
Creating a Child Self-Report Measure of Adverse Events Related to Cancer Treatment; Providing a Voice for the Child Casey Hooke, PhD, RN, PCNS, CPON University of Minnesota School of Nursing Pamela Hinds,
More informationPROMIS Physical Function PROMIS Fatigue PROMIS Sleep-Related Impairment 3 Activities and Pain Impact Scale
Assessment Domains and Surveys Defense and Veterans Rating Scale. Catastrophizing Scale TBI QOL Headache Interference Neuropathic Scale Diagram Physical Physical Function Fatigue Sleep-Related Impairment
More informationChallenges and Opportunities for Using Common PRO Measures in Comparative Effectiveness Research
Challenges and Opportunities for Using Common PRO Measures in Comparative Effectiveness Research Greg Simon, MD, MPH Group Health Research Institute David Cella, PhD Northwestern University Reesa Laws,
More informationPROMIS: What is it, Why Use it, and How to Advance the Mission of Integrative Oncology
PROMIS: What is it, Why Use it, and How to Advance the Mission of Integrative Oncology David Cella, PhD Professor and Chair, Dept. of Medical Social Sciences Northwestern University, Feinberg School of
More informationGuideline scope Persistent pain: assessment and management
National Institute for Health and Clinical Excellence [document type for example, IFP, QRG] on [topic] Document cover sheet Date Version number Editor 30/08/2017 1 NGC Action 1 2 3 4 5 6 7 8 9 10 11 12
More informationQualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin
Qualitative Methods and Patient Reported Outcome Measures Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin Disclosures None Overview What is it? When is it useful? Why do it?
More informationABOUT SMOKING NEGATIVE PSYCHOSOCIAL EXPECTANCIES
Smoking Negative Psychosocial Expectancies A brief guide to the PROMIS Smoking Negative Psychosocial Expectancies instruments: ADULT PROMIS Item Bank v1.0 Smoking Negative Psychosocial Expectancies for
More informationSusan Zieman, M.D., Ph.D. Medical Officer, Geriatrics Branch Division of Geriatrics and Clinical Gerontology National Institute on Aging/National
Susan Zieman, M.D., Ph.D. Medical Officer, Geriatrics Branch Division of Geriatrics and Clinical Gerontology National Institute on Aging/National Institutes of Health ACC U13 Multiple Chronic Conditions
More informationThe Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme
The Chinese University of Hong Kong The Nethersole School of Nursing CTP003 Chronic Disease Management and End-of-life Care Web-based Course for Professional Social and Health Care Workers Copyright 2012
More informationQuality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition
Quality of Life The assessment, analysis and reporting of patient-reported outcomes Third Edition PETER M. FAYERS Institute of Applied Health Sciences, University ofaberdeen School of Medicine and Dentistry,
More informationPATIENT REPORTED OUTCOMES
Introduction to Clinical Research: A Two-week Intensive Course PATIENT REPORTED OUTCOMES Albert W. Wu, MD, MPH Overview 1. Importance of patient perspective 2. Definitions 3. Key concepts to measure as
More informationPROMIS Sexual Function and Satisfaction. Manual
PROMIS Sexual Function and Satisfaction Manual Table of Contents Introduction... 4 Sexual Function and Satisfaction (SexFS) Version 2.0... 5 Introductory Video... 6 About Sexual Function and Satisfaction...
More informationA Review of Patient-Reported Outcome Labeling in the United States ( ) Joseph C. Cappelleri Pfizer Inc
A Review of Patient-Reported Outcome Labeling in the United States (2011-2015) Joseph C. Cappelleri Pfizer Inc Invited oral presentation at the American Statistical Association Biopharmaceutical Section
More informationThe PhenX Toolkit: Standard Measures for Collaborative Research
The PhenX Toolkit: Standard Measures for Collaborative Research Clinical Common Data Elements Task Force (CDETF) November 4, 2016 Carol M. Hamilton, PhD RTI International is a trade name of Research Triangle
More informationThe promise of PROMIS: Using item response theory to improve assessment of patient-reported outcomes
The promise of PROMIS: Using item response theory to improve assessment of patient-reported outcomes J.F. Fries 1, B. Bruce 1, D. Cella 2 1 Department of Medicine, Stanford University School of Medicine,
More informationA Review of FDA PRO Labeling ( ) Ari Gnanasakthy RTI Health Solutions
A Review of FDA PRO Labeling (2011-2015) Ari Gnanasakthy RTI Health Solutions SEVENTH ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP April 27-28, 2016 Silver Spring, MD Disclaimer The views
More informationPerformance of PROMIS and Legacy Measures Among Advanced Breast Cancer Patients and Their Caregivers
Performance of PROMIS and Legacy Measures Among Advanced Breast Cancer Patients and Their Caregivers Alla Sikorskii, PhD Department of Psychiatry Department of Statistics and Probability Michigan State
More informationMigrating a PRO Instrument. Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket)
Migrating a PRO Instrument Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket) Presenter Biographies Serge Bodart is currently based in Montreal, Canada. He has been involved
More informationDEPARTMENT <EXPERIMENTAL-CLINICAL AND HEALTH PSYCHOLOGY... > RESEARCH GROUP <.GHPLAB.. > PSYCHOLOGICAL EVALUATION. Geert Crombez
DEPARTMENT RESEARCH GROUP PSYCHOLOGICAL EVALUATION Geert Crombez PSYCHOLOGICAL EVALUATION Why is psychological evaluation important? What
More informationOvercoming Challenges in Outcome Measurement in Rare Diseases and Pediatric Populations
Overcoming Challenges in Outcome Measurement in Rare Diseases and Pediatric Populations Ninth Annual Patient-Reported Outcome Consortium Workshop April 25 26, 2018 Silver Spring, MD Disclaimer The views
More informationNIH Toolbox. Technical Manual
NIH Toolbox Technical Manual Michael Kallen, PhD, Jerry Slotkin, PhD, James Griffith, PhD, Susan Magasi, PhD, John Salsman, PhD, Cindy Nowinski, MD, PhD, and Richard Gershon, PhD September 27, 2012 NIH
More informationRichard C. Gershon, PhD.
Richard C. Gershon, PhD. gershon@northwestern.edu www.healthmeasures.net Collectively PROMIS and the NIH Toolbox consist of over 250 measures. This particular presentation is limited to describing the
More informationLessons from the Development of a Canadian National System of Surveillance
Lessons from the Development of a Canadian National System of Surveillance NATHALIE JETTÉ MD, MSc, FRCPC Assistant Professor Neurology Hotchkiss Brain Institute Calgary Institute of Population and Public
More informationOncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications
1 ONSQIR 1 Non-PRQS Measure Oncology Nursing Society Registry in Collaboration with CE City 2015 Performance Measure Specifications Performance Measure Name: Symptom Assessment 1-o1a Symptom Assessment
More informationElectronic patient and parent reported outcomes in pediatric clinical practice Haverman, L.
UvA-DARE (Digital Academic Repository) Electronic patient and parent reported outcomes in pediatric clinical practice Haverman, L. Link to publication Citation for published version (APA): Haverman, L.
More informationRARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process. Disclaimer:
RARE DISEASE WORKSHOP SERIES Improving the Clinical Development Process Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the Kakkis EveryLife Foundation for educational
More informationLessons learned along the path to qualification of an IBS outcome measure*
Lessons learned along the path to qualification of an IBS outcome measure* Stephen Joel Coons, PhD Patient-Reported Outcome (PRO) Consortium Critical Path Institute IMMPACT-XX WASHINGTON, DC July 14, 2017
More informationTwo-item PROMIS global physical and mental health scales
Hays et al. Journal of Patient-Reported Outcomes (2017) 1:2 DOI 10.1186/s41687-017-0003-8 Journal of Patient- Reported Outcomes RESEARCH Open Access Two-item PROMIS global physical and mental health scales
More informationQuality of Life Instrument Development in Adults. American Cochlear Implant Alliance /8/18
Quality of Life Instrument Development in Adults Ted McRackan MD, MSCR American Cochlear Implant Alliance 2018 3/8/18 Disclosures K12 CTSA award (UL1TR001450) Doris Duke Foundation PERK award American
More informationPurpose of Workshop. Faculty. Culturally Sensitive Research. ISOQOL Workshop 19 Oct 2005
Introduction to ing Health-Related Measures in Diverse Populations Pre-conference Workshop 2 The International Society for Quality of Life Research Center for Aging in Diverse Communities: A Resource Center
More informationAssessing Consumer Responses to RRP: Experience at PMI in Developing Fit-for-Purpose Self-Report Instruments
Assessing Consumer Responses to RRP: Experience at PMI in Developing Fit-for-Purpose Self-Report Instruments C. Chrea, E. Spies, E. Afolalu, N. Mainy, S. Gallot, P. Binggeli, E. Clerc, R. Weitkunat PMI
More informationIN A RECENT AMERICAN Congress of Rehabilitation
S1 INTRODUCTION Advances in Outcomes Measurement in Rehabilitation Medicine: Current Initiatives from the National Institutes of Health and the National Institute on Disability and Rehabilitation Research
More informationDENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA
Quality ID #109: Osteoarthritis (OA): Function and Pain Assessment National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationMeasure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care
Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: Percentage
More informationSECOND ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP
SECOND ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP March 15, 2011 Silver Spring, MD Co-sponsored by To Combine or Not Combine: Individual Symptom Scores Versus Summary Scores Moderator: Margaret
More informationElectronic Capture of PROs in NCI Clinical Trials
Electronic Capture of PROs in NCI Clinical Trials Lori Minasian, MD, FACP Deputy Director, Division of Cancer Prevention, NCI July 27, 2017 Vision for PROs in NCI Clinical Trials Incorporate patient reported
More informationMeasures of Self-Efficacy
Arthritis Care & Research Vol. 63, No. S11, November 2011, pp S473 S485 DOI 10.1002/acr.20567 2011, American College of Rheumatology PSYCHOLOGICAL MEASURES Measures of Self-Efficacy Arthritis Self-Efficacy
More informationPatient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington
Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance Paul-Martini-Stiftung Berlin-Brandenburgische Akademie der Wissenschaften 6 March 2008 10:45 11:05 Donald L. Patrick
More informationPANEL QUESTIONS FOR REGULATORY CONSIDERATION
PANEL QUESTIONS FOR REGULATORY CONSIDERATION Biometric Monitoring Devices (BMDs) to Quantitatively Assess Quality-of-Life (QoL) Domains: Mobility/Frailty, Sleep, & Cognition www.cpath.org/camd QUESTIONS
More informationQuality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care
Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
More informationDeveloping and Testing Survey Items
Developing and Testing Survey Items William Riley, Ph.D. Chief, Science of Research and Technology Branch National Cancer Institute With Thanks to Gordon Willis Contributions to Self-Report Errors Self-report
More informationAdditional resources from Lunch and Learn: The Good, Bad, and the Ugly: Treatment of Complex Regional Pain Syndrome in Pediatrics
Additional resources from Lunch and Learn: The Good, Bad, and the Ugly: Treatment of Complex Regional Pain Syndrome in Pediatrics 1) Summary of the outcome measures from reference: Packham T, MacDermid
More informationQuestionnaire Development and Testing. Barbara J. Stussman Survey Statistician NIH/NCCAM
Questionnaire Development and Testing Barbara J. Stussman Survey Statistician NIH/NCCAM Acknowledgments Gordon Willis, Ph.D. Applied Research Program, NCI William Riley, Ph.D. Chief, Science of Research
More informationQuestionnaire Development and Testing. Acknowledgments. Outline of Lecture. Barbara J. Stussman Survey Statistician NIH/NCCAM
Questionnaire Development and Testing Barbara J. Stussman Survey Statistician NIH/NCCAM Acknowledgments Gordon Willis, Ph.D. Applied Research Program, NCI William Riley, Ph.D. Chief, Science of Research
More informationIntegrated IAPT Data Guide
Version Date Summary of changes Draft Nov 16 Initial version for feedback at early implementer workshop v3 Feb 17 Iterated version on Yammer for feedback v4 March 17 Version agreed at Outcomes & Informatics
More informationEuropean Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC
Quality of life of cardiac patients in Europe: HeartQoL Project Stefan Höfer The HeartQol Questionnaire: methodological and analytical approaches Patients Treatment Is quality of life important in cardiovascular
More informationSources of Comparability Between Probability Sample Estimates and Nonprobability Web Sample Estimates
Sources of Comparability Between Probability Sample Estimates and Nonprobability Web Sample Estimates William Riley 1, Ron D. Hays 2, Robert M. Kaplan 1, David Cella 3, 1 National Institutes of Health,
More informationUsing Performance and Outcome Measures for Enhancing the Quality of Behavioral Health Care Services
Using Performance and Outcome Measures for Enhancing the Quality of Behavioral Health Care Services Dennis Morrison, PhD Chief Clinical Officer Netsmart Technologies @DrDennyM Knowledge Without Data is
More informationEngaging with the new EU regulatory landscape for medical devices. Challenges and opportunities
NORE (Network of Orthopaedic Registries of Europe) an EFORT standing committee NIMAC symposium Engaging with the new EU regulatory landscape for medical devices. Challenges and opportunities Luca Orlandini
More information